Melissa Strange

Melissa Strange currently serves as Chief Financial Officer at EnteroBiotix and holds several key financial roles across multiple organizations, including Founding Chief Financial Officer at Bind Research, where innovative approaches to drug discovery are explored. With extensive experience in finance and advisory capacities, Melissa also contributes as Chair and Vice-Chair of the Finance and Tax Advisory Committee at the BioIndustry Association, along with positions at Infinitopes, Oxford Brain Diagnostics Ltd, and Kiln Consulting LLP, where Fractional CFO services are provided to life science SMEs. Educational qualifications include an Executive Master of Business Administration from Saïd Business School, University of Oxford, along with various finance and law-related credentials from distinguished institutions.